News

PharmExec16h
FDA Grants Accelerated Approval to AstraZeneca, Daiichi Sankyo’s Datroway for Previously Treated, Locally Advanced or Metastatic EGFR-Mutated NSCLC
Approval was based on results from the Phase II TROPION-Lung05 trial, which showed that Datroway demonstrated a strong ...
PharmExec13h
Roche’s Next-Gen Bispecific Antibody Shows Early Promise in Hemophilia A
Early results from the Phase I/II NXTAGE trial show that NXT007 may achieve hemostatic normalization in patients with ...
PharmExec21h
Novo Nordisk Ends Hims & Hers Collaboration
As such, Novo Nordisk ended its collaboration with Hims & Hers over concerns of illegal mass compounding and deceptive ...
PharmExec21h
The Fight for Alzheimer’s Research Funding
The ADDF’s CFO discusses the areas that foundation is raising money for and how its reacting to the current economic ...
PharmExec21h
Developing FP&A Strategies in Today’s Environment: Q&A with Jennifer Kyle
At the moment, FP&A in pharma is going through a complex period of change. While new technologies are making it easier to collect and analyze data, external factors are making it much harder to ...